RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-4754
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_1108700; Gene model (P.falciparum): PF3D7_0509100; Gene product: structural maintenance of chromosomes protein 4, putative (SMC4)
Details mutation: 'promoter swap mutant': the promoter of smc4 replaced with the ama1 promoter (PBANKA_0915000).
Transgene
Transgene not Plasmodium: GFP (gfp-mu3)
Promoter: Gene model: PBANKA_1133300; Gene model (P.falciparum): PF3D7_1357100; Gene product: elongation factor 1-alpha (eef1a)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Phenotype Asexual bloodstage; Gametocyte/Gamete; Fertilization and ookinete; Oocyst; Sporozoite; Liver stage;
Last modified: 7 April 2020, 17:41
  *RMgm-4754
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 32049018
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 507cl1 (RMgm-7)
Other information parent lineP.berghei ANKA 507cl1 (RMgm-7) is a reference ANKA mutant line which expresses GFP under control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190).
The mutant parasite was generated by
Name PI/ResearcherPandey R, Tewari R
Name Group/DepartmentSchool of Life Sciences, Queens Medical Centre
Name InstituteUniversity of Nottingham
CityNottingham
CountryUK
Name of the mutant parasite
RMgm numberRMgm-4754
Principal nameP(ama1)smc4 (SMC4PTD)
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageWe were unable to detect any particular impaired phenotype in the SMC2PTD and SMC4PTD lines at the asexual blood stage (schizogony), and the parasite formed a similar number of schizonts and nuclei compared with the WTGFP line.
Fertilization and zygote formation leading to ookinete conversion was reduced to 10%–15% compared with the WTGFP line. The ookinete motility assay showed normal movement of SMC4PTD ookinetes compared with WT.
Gametocyte/GameteWe observed an ~50% reduction in the number of exflagellation centers during male gametogenesis.
Fertilization and ookineteFertilization and zygote formation leading to ookinete conversion was reduced to 10%–15% compared with the WTGFP line. The ookinete motility assay showed normal movement of SMC4PTD ookinetes compared with WT.
OocystIn the mosquito gut on 9, 14, and 21 days post-infection, we detected significantly fewer oocysts in the SMC2PTD and SMC4PTD lines. Furthermore, the oocysts were considerably smaller compared with those of WTGFP, with unequal distribution and clusters of DNA in some oocysts at 14 and 21 days post-infection. No sporogony or endomitosis was observed within oocysts
SporozoiteNo sporogony or endomitosis was observed within oocysts. We were also unable to detect sporozoites in the mosquito salivary glands; hence, no parasite transmission from infected mosquitoes to mice was observed for either SMC2PTD or SMC4PTD parasite lines in bite-back experiments
Liver stageWe were also unable to detect sporozoites in the mosquito salivary glands; hence, no parasite transmission from infected mosquitoes to mice was observed for either SMC2PTD or SMC4PTD parasite lines in bite-back experiments
Additional remarks phenotype

Mutant/mutation
In the 'promoter swap mutant': the promoter of smc4 has been replaced with the asexual blood stage promoter ama1 (PBANKA_0915000). This promoter is active in asexual blood stages but not in gametocytes.

Protein (function)
An essential component of chromosome dynamics is a family of structural maintenance of chromosomes proteins, originally described in budding yeast as stability of minichromosomes (SMC) proteins, which are implicated in chromosome segregation  and condensation. Most eukaryotes have at least six genes encoding SMC proteins (each 110–170 kDa, with a central hinge region and N- and C-terminal globular domains with Walker A and Walker B motifs forming the ATPase head domain). The six SMCs can be classified as subunits of condensin (SMC2 and SMC4, required for chromosomal condensation), cohesin (SMC1 and SMC3, required for chromosomal segregation), and the SMC5-SMC6 complex (involved in DNA repair and homologous recombination. Higher eukaryotic organisms have two condensin complexes, condensin I and condensin II, whereas many single-celled organisms such as yeast have only one condensin complex.
SMC2 and SMC4 form the core structure for both condensin I and condensin II in higher eukaryotes and interact with three additional non-SMC components: one kleisin and two Heat protein subunits. Kleisin Ig (CAP-H), Heat IA (CAP-D2), and Heat IB (CAP-G) form the condensin I complex, whereas Kleisin IIb (CAP-H2), Heat IIA (CAP-D3), and Heat IIB (CAP-G2) form the condensin II complex. 
Domain analysis of Plasmodium SMC2 and SMC4 revealed a conserved domain architecture for both SMC2 and SMC4 . A comparative sequence analysis revealed low 
sequence similarity and identity (29%–34%), except for the SMC4 homolog in Arabidopsis thaliana (65%), although there was similarity in size and overall domain structure when compared with the proteins in the other studied organisms. 
We found the P. berghei SMC4 N-terminal ATPase domain divided in two by a 44 amino acid insertion; a similar pattern has been observed in other Plasmodium species.
P. berghei SMC2 (PBANKA_1416900), SMC4 (PBANKA_1108700)

Phenotype
To investigate the function of SMC2 and SMC4 during cell division in male gametogenesis, we used a promoter trap double homologous recombination (PTD) approach to downregulate gene expression at this stage by placing each of the two genes under the control of the AMA1 promoter. AMA1 is known to be highly expressed in asexual blood stages, but not during sexual differentiation. This strategy resulted in the successful generation of two transgenic parasite lines: P(ama1)smc2 (SMC2PTD) and P(ama1)smc4 (SMC4PTD)

SMC2 is expressed both in asexual blood stages and (male) gametocytes. Knock-out of the smc2 gene is not possible since it has an essential role in asexual blood stages. In the promoter swap mutant SMC2 is expressed in asexual blood stages but is down-regulated in (male) gametocytes.

We were unable to detect any particular impaired phenotype in the SMC2PTD and SMC4PTD lines at the asexual blood stage (schizogony), and the parasite formed a similar number of schizonts and nuclei compared with the WTGFP line.
Fertilization and zygote formation leading to ookinete conversion was reduced to 10%–15% compared with the WTGFP line. The ookinete motility assay showed normal movement of SMC4PTD ookinetes compared with WT.

We observed an ~50% reduction in the number of exflagellation centers during male gametogenesis.

Fertilization and zygote formation leading to ookinete conversion was reduced to 10%–15% compared with the WTGFP line. The ookinete motility assay showed normal movement of SMC4PTD ookinetes compared with WT.

In the mosquito gut on 9, 14, and 21 days post-infection, we detected significantly fewer oocysts in the SMC2PTD and SMC4PTD lines. Furthermore, the oocysts were considerably smaller compared with those of WTGFP, with unequal distribution and clusters of DNA in some oocysts at 14 and 21 days post-infection. No sporogony or endomitosis was observed within oocysts.

We were also unable to detect sporozoites in the mosquito salivary glands; hence, no parasite transmission from infected mosquitoes to mice was observed for either SMC2PTD or SMC4PTD parasite lines in bite-back experiments

Additional information
 
Other mutants


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1108700
Gene Model P. falciparum ortholog PF3D7_0509100
Gene productstructural maintenance of chromosomes protein 4, putative
Gene product: Alternative nameSMC4
Details of the genetic modification
Short description of the mutation'promoter swap mutant': the promoter of smc4 replaced with the ama1 promoter (PBANKA_0915000).
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationConditional gene knockdown constructs (SMC2PTD and SMC4PTD) were designed using Pama1 (pSS368) (Sebastian et al., 2012).
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP (gfp-mu3)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitegfp (FACS)
Promoter of the selectable markereef1a
Selection (positive) procedureFACS (flowsorting)
Selection (negative) procedureNo
Additional remarks genetic modificationThe GFP gene (1 copy) has been inserted into the 230p locus (PBANKA_030600) by double cross-over integration.
Additional remarks selection procedureThis reporter mutant expressing GFP does not contain a drug-selectable marker. This mutant has been selected by FACS sorting after transfection based on GFP fluorescence.
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1133300
Gene Model P. falciparum ortholog PF3D7_1357100
Gene productelongation factor 1-alpha
Gene product: Alternative nameeef1a
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4